|
Quality of life scores in patients randomised to fluticasone or placebo. |
||||
| Fluticasone |
Placebo |
|||
| Mean difference at 12 months |
Mean difference at 12 months |
Effect size % partial eta2 |
Significance between groups |
|
|
|
||||
| SGRQ total score |
-0.98 |
-1.43 |
< 0.1% |
P = 0.83 |
| EQ5D total score |
-0.03 |
0.03 |
0.2% |
P = 0.66 |
| EQ5D VAS |
-2.16 |
-0.29 |
< 0.1% |
P = 0.97 |
|
(a) SGRQ = St George's respiratory questionnaire. (b) EQ5D = EuroQol 5D generic questionnaire. (c) Significance between groups was assessed using analysis of co-variance. | ||||
Choudhury et al. Respiratory Research 2007 8:93 doi:10.1186/1465-9921-8-93 |
||||